Integrated neuroendocrine immune risk factors in relation to rheumatoid arthritis: Should rheumatologists now adopt a model of a multiyear, presymptomatic phase?

Scandinavian Journal of Rheumatology

Volumn 34, Issue 5, 2005, Pages 342-352

  Masi, Alfonse T ^a   Aldag, J C ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CYTOKINE; HORMONE; RHEUMATOID FACTOR;

ADRENAL CORTEX FUNCTION; ADRENAL INSUFFICIENCY; CHRONIC INFLAMMATION; CIGARETTE SMOKING; CORRELATION ANALYSIS; DISEASE PREDISPOSITION; FAMILIAL DISEASE; GENETIC MARKER; HUMAN; IMMUNE SYSTEM; IMMUNOLOGY; METABOLIC DISORDER; NEUROENDOCRINE SYSTEM; PATHOGENESIS; POSTMENOPAUSE; PRECURSOR; PREMENOPAUSE; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; RISK FACTOR;

ARTHRITIS, RHEUMATOID; HUMANS; MODELS, BIOLOGICAL; NEUROSECRETORY SYSTEMS; RHEUMATOLOGY; RISK FACTORS;

EID: 27544470523     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.1080/03009740500327735     Document Type: Review

References (100)

1. Aho K, Palosuo T, Raunio V, Puska P, Aromaa A, Salonen JT. When does rheumatoid disease start? Arthritis Rheum 1985;28:485-9.
2. Aho K, Palosuo T, Niemela N, Takala J. Rheumatoid factor seroconversions in relation to clinical rheumatoid arthritis. Ann Clin Res 1985;17:15-18.
3. Aho K, Heliovaara M, Maatela J, Tuomi T, Palosuo T. Rheumatoid factors antedating clinical rheumatoid arthritis. J Rheumatol 1991;18:1282-4.
4. Aho K, von Essen R, Kurki P, Palosuo T, Heliovaara M. Antikeratin antibody and antiperinuclear factor as markers for subclinical rheumatoid disease process. J Rheumatol 1993;20:1278-81.
5. Rantapaa-Dahlqvist S. Diagnostic and prognostic significance of autoantibodies in early rheumatoid arthritis. Scand J Rheumatol 2005;34:83-96.
6. Aho K, Palosuo T, Heliovaara M, Knekt P, Alha P, von Essen R. Antifilaggrin antibodies within "normal" range predict rheumatoid arthritis in a linear fashion. J Rheumatol 2000;27:2743-6.
7. Rantapaa-Dahlqvist S, de Jong BAW, Berglin E, Hallmans G, Wadell G, Stenlund H, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003;48:2741-9.
8. Nielen MM, van Schaardenburg D, Reesink HW, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning MH, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004;50:380-6.
9. Klareskog L, Alfredsson L, Rantapaa-Dahlqvist S, Berglin E, Stolt P, Padyukov L. What precedes development of rheumatoid arthritis? Ann Rheum Dis 2004;63 Suppl 2, ii28-31.
10. Hasstedt SJ, Clegg DO, Ingles L, Ward RH. HLA-linked rheumatoid arthritis. Am J Hum Genet 1994;55:738-46.
11. Kwoh CK, Venglish C, Lynn AH, Whitley DM, Young E, Chakravarti A. Age, sex, and the familial risk of rheumatoid arthritis. Am J Epidemiol 1996;144:15-24.
12. Heliovaara M, Aho K, Aromaa A, Knekt P, Reunanen A. Smoking and risk of rheumatoid arthritis. J Rheumatol 1993;20:1830-5.
13. Uhlig T, Hagen KB, Kvien TK. Current tobacco smoking, formal education and the risk of rheumatoid arthritis. J Rheumatol 1999;26:47-54.
14. Stolt P, Bengtsson C, Nordmark B, Lindblad S, Lundberg I, Klareskog L, et al. Quantification of the influence of cigarette smoking on rheumatoid arthritis; results from a population based case-control study, using incident cases. Ann Rheum Dis 2003;62:835-41.
15. Masi AT, Chang HJ. Cigarette smoking and other acquired risk factors for rheumatoid arthritis. In Kaufman LD, Varga J, editors. Rheumatic diseases and the environment. New York: Chapman & Hall, 1999: 111-27.
16. Aho K, Heliovaara M. Risk factors for rheumatoid arthritis. Ann Med 2004;36:242-51.
17. Reckner Olsson A, Skogh T, Wingren G. Aetiological factors of importance for the development of rheumatoid arthritis. Scand J Rheumatol 2004;33:300-6.
18. Laskin MD, Pope JE, Krizova A, Ouimet JM, Goodwin JL. Are infections increased in rheumatoid arthritis (RA) prior to diagnosis? Results of a case control study of RA compared to non-inflammatory musculoskeletal disorders. Scand J Rheumatol 2005;34:74-8.
19. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987;30:1205-13.
20. Choy EHS, Panayi GS. Mechanisms of disease: cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 2001;344:907-16.
21. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995;332:1351-62.
22. Masi AT, Feigenbaum SL, Chatterton RT, Cutolo M. Integrated hormonal-immunological-vascular ("H-I-V" triad) systems interactions in rheumatic diseases. Clin Exp Rheumatol 1995;13:203-16.
23. Masi AT, Feigenbaum SL, Chatterton RT. Hormonal and pregnancy relationships to rheumatoid arthritis: convergent effects with immunologic and microvascular systems. Semin Arthritis Rheum 1995;25:1-27.
24. Masi AT, Bijlsma JWJ, Chikanza IC, Pitzalis C, Cutolo M. Neuroendocrine, immunologic, and microvascular systems interactions in rheumatoid arthritis: physiopathogenetic and therapeutic perspectives. Semin Arthritis Rheum 1999;29:65-81.
25. Masi AT. Hormonal and immunologic risk factors for the development of rheumatoid arthritis: an integrative physiopathogenetic perspective. Rheum Dis Clin N Am 2000;26:775-803.
26. Straub RH, Besedovsky HO. Integrated evolutionary, immunological, and neuroendocrine framework for the pathogenesis of chronic disabling inflammatory diseases. FASEB J 2003;17:2176-83.
27. Masi AT, Aldag JC, Jacobs JWG. Rheumatoid arthritis: neuroendocrine immune integrated physiopathogenetic perspectives and therapy. Rheum Dis Clin N Am 2005;31:131-60.
28. Masi AT, DaSilva JAP, Cutolo M. Perturbations of hypothalamic-pituitary- gonadal (HPG) axis and adrenal androgen (AA) functions in rheumatoid arthritis. Bailliere's Clin Rheum 1996;10:295-332.
29. Haskard DO. Accelerated atherosclerosis in inflammatory rheumatic diseases. Scand J Rheumatol 2004;33:281-92.
30. Wallberg-Jonsson S, Ohman M-L, Rantapaa-Dahlqvist S. Which factors are related to the presence of atherosclerosis in rheumatoid arthritis? Scand J Rheumatol 2004;33:373-9.
31. Alkaabi JK, Ho M, Levison R, Pullar T, Belch JJ. Rheumatoid arthritis and macrovascular disease. Rheumatology (Oxford) 2003;42:292-7.
32. Hetland ML, Skjodt H, Ostergaard M, Nielsen HJ, Johansen JS. Initial levels and early changes in plasma VEGF correlate closely with long-term clinical outcome in RA patients treated with TNF-alfa antagonists. Abstract 0159. Ann Rheum Dis 2003;62 Suppl 1.
33. Gedeit RG. Tumor necrosis factor-alpha induces E-selectin expression on vascular endothelial cells. Crit Care Med 1996;24:1543-6.
34. Mojcik CF, Shevach EM. Adhesion molecules. A rheumatologic perspective. Arthritis Rheum 1997;40:991-1004.
35. Hurlimann D, Forster A, Noll G, Enseleit F, Chenevard R, Distler O, et al. Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation 2002;106:2184-7.
36. Liu D, Dillon JS. Dehydroepiandrosterone stimulates nitric oxide release in vascular endothelial cells: evidence for a cell surface receptor. Steroids 2004;69:279-89.
37. Masi AT, Medsger TA Jr. Epidemiology of the rheumatic diseases. In McCarty DJ, editor. Arthritis and allied conditions, 11th edn. Philadelphia: Lea & Febiger, 1989: pp 16-54.
38. Masi AT. Incidence of rheumatoid arthritis: do the observedage-sex interaction patterns support a role of androgenic-anabolic steroid deficiency in its pathogenesis? Br J Rheumatol 1994;33:697-9.
39. Hench PS. The ameliorating effect of pregnancy on chronic atrophic (infectious rheumatoid) arthritis, fibrositis, and intermittent hydrarthrosis. Proc Mayo Clin 1938;13:161-7.
40. Cutolo M, Villaggio B, Foppiani L, Briata M, Sulli A, Pizzorni C, et al. The hypothalamic-pituitary-adrenal and gonadal axes in rheumatoid arthritis. Ann N Y Acad Sci 2000;917:835-43.
41. Straub RH, Cutolo M. Involvement of the hypothalamic-pituitary-adrenal/ gonadal axis and the peripheral nervous system in rheumatoid arthritis: viewpoint based on a systemic pathogenetic role. Arthritis Rheum 2001;44:493-507.
42. Cutolo M, Villaggio B, Craviotto C, Pizzorni C, Seriolo B, Sulli A. Sex hormones and rheumatoid arthritis. Autoimmun Rev 2002;1:284-9.
43. Straub RH, Scholmerich J, Cutolo M. The multiple facets of premature aging in rheumatoid arthritis. Arthritis Rheum 2003;48:2713-21.
44. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne Parikka R, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-50.
45. Bergman RN. Pathogenesis and prediction of diabetes mellitus: lessons from integrative physiology. Mt Sinai J Med 2002;69:280-90.
46. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
47. Benjamin SM, Valdez R, Geiss LS, Rolka DB, Narayan KM. Estimated number of adults with prediabetes in the US in 2000: opportunities for prevention. Diabetes Care 2003;26:645-9.
48. Lowensteyn I, Joseph L, Levinton C, Abrahamowicz M, Steinert Y, Grover S. Can computerized risk profiles help patients improve their coronary risk? The results of the Coronary Health Assessment Study (CHAS). Prev Med 1998;27:730-7.
49. Liao Y, McGee DL, Cooper RS, Sutkowski MB. How generalizable are coronary risk prediction models? Comparison of Framingham and two national cohorts. Am Heart J 1999;137:837-45.
50. Snyderman R, Williams RS. Prospective medicine: the next health care transformation. Acad Med 2003;78:1079-84.
51. Hood L, Heath JR, Phelps ME, Lin B. Systems biology and new technologies enable predictive and preventative medicine. Science 2004;306:640-3.
52. Framingham Heart Study: You changed America's heart, http://www.nhlbi. nih.gov/about/framingham/fhsbro. pdf
53. Braitman LE, Davidoff F. Predicting clinical states in individual patients. Ann Intern Med 1996;125:406-12.
54. Burch PRJ. A genetic theory of inflammatory polyarthritis. Lancet 1963;1:1253 and 2:636-7.
55. Harris ED Jr. Rheumatoid arthritis. Philadelphia: WB Saunders, 1997.
56. Ollier W, Winchester R. The germline and somatic genetic basis for rheumatoid arthritis. Curr Dir Autoimmun 1999;1:166-93.
57. Dieppe P. Strategies for the prevention of osteoarthritis. Int J Tissue React 1993;15:93-7.
58. Felson DT, Zhang Y. An update on the epidemiology of knee and hip osteoarthritis with a view to prevention. Arthritis Rheum 1998;41:1343-55.
59. Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Alcohol intake and risk of incident gout in men: a prospective study. Lancet 2004;363:1277-81.
60. Masi AT, Josipovic DB, Jefferson WE. Low adrenal androgenic-anabolic steroids in women with rheumatoid arthritis (RA): gas-liquid Chromatographic studies of RA patients and matched normal control women indicating decreased 11-deoxy-17-ketosteroid excretion. Semin Arthritis Rheum 1984;14:1-23.
61. Masi AT, Aldag JC, Chatterton RT, Adams RF, Kitabchi AE. Adrenal androgen and glucocorticoid dissociation in premenopausal rheumatoid arthritis: a significant correlate or precursor to onset? Z Rheumatol 2000;59, Suppl 2, 54-61.
62. Helzlsouer KJ, Alberg AJ, Gordon GB, Longcope C, Bush TL, Hoffman SC, et al. Serum gonadotropins and steroid hormones and the development of ovarian cancer. J Am Med Assoc 1995;274:1926-30.
63. Rothman N, Cantor KP, Blair A, Bush D, Brock JW, Helzlsouer K, et al. A nested case-control study of non-Hodgkin lymphoma and serum organochlorine residues. Lancet 1997;350:240-4.
64. Alberg AJ, Gordon GB, Hoffman SC, Comstock GW, Helzlsouer KJ. Serum dehydroepiandrosterone and dehydroepiandrosterone sulfate and the subsequent risk of developing colon cancer. Cancer Epidemiol Biomarkers Prev 2000;9:517-21.
65. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
66. Masi AT, Chatterton RT, Comstock GW, Malamet RL, Hochberg MC. Decreased serum dehydroepiandrosterone sulfate (DHAS) levels before onset of RA in younger, premenopausal women: a controlled, prospective study. Arthritis Rheum 1994;37 Suppl 315.
67. Masi AT, Chatterton RT, Aldag JC, Comstock GW, Helzlsouer KJ, Hoffman SC, et al. Decreased serum dehydroepiandrosterone sulfate (DHEAS) levels in menstruating women prior to onset of RA before age 50: independent reference laboratory assays validate previous significant results. Arthritis Rheum 1998;41 Suppl 126.
68. Masi AT, Chatterton RT, Aldag JC, Malamet RL. Perspectives on the relationship of adrenal steroids to rheumatoid arthritis. Ann N Y Acad Sci 2002;966:1-12.
69. Masi AT, Chatterton RT, Lu YC, Comstock GW, Malamet RL, Hochberg MC, et al. Low serum dehydroepiandrosterone sulfate (DHAS) levels, rheumatoid factor (RF) and elevated serum tumor necrosis factor α (TNFα) without cytokine receptor (CR) elevations predict long-term onset of RA in women: a controlled, prospective study. Arthritis Rheum 1995;38 Suppl 214.
70. Masi AT, Chatterton RT, Comstock GW, Helzlsouer KJ, Hoffman SC, Malamet RL, et al. A positive history of rheumatoid arthritis (RA) in a first degree relative (FDR) or a positive serological predictor for RA prior to disease onset before age 50 were uniformly present in a sample of younger, premenopausal incident cases: results of a prospective, controlled study. Arthritis Rheum 1998;41 Suppl 126.
71. Lobo RA, Paul WL, Goebelsmann U. Dehydroepiandrosterone sulfate as an indicator of adrenal androgen function. Obstet Gynecol 1981;57:69-73.
72. Kabowiak I, Petrillo G, Zovato S, Sinsoncini M, Eottardo C, Scaroni C, et al. Relationships between serum dehydroepiandrosterone sulphate, cortisol and age in healthy women [Abstract P2-654]. The Endocrine Society Program and Abstracts: ENDO, 1998: 385.
73. Masi AT, Chatterton RT, Fecht T, Aldag JC, Comstock GW, Helzlsour KJ, et al. Dissociation of serum dehydroepiandrosterone sulfate (DHEAS) and cortisol levels in younger premenopausal women prior to onset of rheumatoid arthritis (RA) before age 50: results of a prospective, controlled study. Arthritis Rheum 1998;41 Suppl 126.
74. Masi AT, Chrousos GP, Bornstein SR. Enigmas of adrenal androgen and glucocorticoid dissociation in premenopausal onset rheumatoid arthritis. J Rheumatol 1999;26:247-250.
75. Merlino LA, Cerhan JR, Criswell LA, Mikuls TR, Saag KG. Estrogen and other female reproductive risk factors are not strongly associated with the development of rheumatoid arthritis in elderly women. Semin Arthritis Rheum 2003;33:72-82.
76. Masi AT, Chrousos GP. Polycystic ovarian syndrome and rheumatoid arthritis: possible physiopathogenetic clues to hormonal influences on chronic inflammation. Semin Arthritis Rheum 2003;33:67-71.
77. Masi AT, Aldag JC, Malamet RL, Sipe JD, Teodorescu M, Peter JB, et al. Heavy smoking of 30+ cigarettes daily (HS 30+/ d) significantly predicted onset of rheumatoid arthritis (RA) in both genders, and was an independent risk factor from either rheumatoid factor positivity (RF+) or development of the disease in a first degree relative (FDR+). Arthritis Rheum 2001;44 Suppl 105.
78. Masi AT, Aldag JC, Malamet RL, Peter JB. Perturbations in serum levels of interleukin-1 beta (IL-1β) and IL-1 receptor antagonist (IL-1Ra) before clinical rheumatoid arthritis (pre-RA) in women with younger versus older onset. Arthritis Rheum 2002;45 Suppl 101.
79. Masi AT, Fecht T, Aldag JC, Comstock GW, Hoffman S, Malamet RL. History of currently smoking cigarettes, but not years of education, correlated with the subsequent development of rheumatoid arthritis: preliminary findings from a community-wide, prospective, nested, case-control study. Arthritis Rheum 1996;39 Suppl 301.
80. Masi AT, Aldag JC, Cooling MB, Chatterton RT, Sipe JD, Malamet RL. Cigarette smoking increased rheumatoid arthritis risks in postmenopausal women and men independently of baseline C-reactive protein (CRP) and prolactin (PRL) levels. Arthritis Rheum 2003;48 Suppl 394.
81. Masi AT, Aldag JC, Cooling MB, Chatterton RT, Malamet RL. Rheumatoid arthritis risks were not affected by baseline serum prolactin (PRL), cortisol (C), or PRL:C ratio levels prior to clinical onset (pre-RA) in postmenopausal women or men. Arthritis Rheum 2003;48:S394.
82. Masi AT, Aldag JC, Fecht T, Teodorescu M, Sipe JD, Agopian MS. Rheumatoid factor positivity (RF+) and current cigarettes smoking (CCS+) of 30+ daily are independent, long-term predictors of RA. Arthritis Rheum 1997;40 Suppl 312.
83. Masi AT, Aldag JC, Chatterton RT, Malamet RL, Comstock GW, Helzlsour KJ, et al. Precursor risk markers (RMs) were identified in 94% of 18 pre-rheumatoid arthritis (pre-RA) males compared to 28% of 72 matched controls (CN) in a community-based, prospective study. Arthritis Rheum 2000;43 Suppl 167.
84. Masi AT, Aldag JC, Chatterton RT, Teodorescu M, Malamet RL, Comstock GW, et al. Independent risk markers (RMs) for RA onset in males include: rheumatoid arthritis (RA) in a first degree relative (FDR+); rheumatoid factor (RF+); combined low serum cortisol and testosterone (low C&T), and heavy cigarette smoking (CS 30+/d). Arthritis Rheum 2000;43 Suppl 70.
85. Masi AT, Chatterton RT, Comstock GW, Malamet RL, Hochberg MC. Decreased androgenic-anabolic (AA) hor-mone levels in sera of white women before onset of RA: a controlled, prospective study. Arthritis Rheum 1993;36 Suppl 176.
86. Masi AT, Aldag JC, Malamet RL, Sipe JD, Teodorescu M, Peter JB, et al. Elevated serum C-reactive protein (CRP+) significantly associated with elevated serum rheumatoid factors (RF+) in male rheumatoid arthritis long before onset of clinical disease (pre-RA), but not in controls. Arthritis Rheum 2001;44 Suppl 105.
87. Masi AT, Aldag JC, Pirzada FA, Pirzada N, Chatterton RT, Malamet RL, et al. Serum hormone and biological mediator correlations were found many years before onset of rheumatoid arthritis (RA) in 18 pre-RA males, but not in 72 matched controls (CN). Arthritis Rheum 2000;43 Suppl 158.
88. Masi AT, Aldag JC, Chatterton RT, Malamet RL. Basal serum IL-1β correlations with glucocorticoid precursor and sex steroid levels differed significantly in men and women before onset of rheumatoid arthritis (pre-RA) versus their matched controls. Arthritis Rheum 2004;50 Suppl 352-3.
89. Schafer JL. Imputation of missing covariates under a general linear mixed model. Technical report, Department of Statistics, Penn State University.
90. Demirtas H. Simulation driven inferences for multiply imputated longitudinal datasets. Stat Neerl 2004;58:466-82.
91. Schafer JL. Analysis of incomplete multivariate data. London: Chapman & Hall, 1997.
92. Schafer JL. Multiple imputation: a primer. Stat Methods Med Res 1999;8:3-5.
93. SPSS (v13.0) for Windows, Chicago: SPSS Inc., 2004.
94. Rothman KJ, Greenland S. Causation and causal inference in epidemiology. Am J Public Health 2005;95 Suppl 144-50.
95. Volg D, Falk W, Dorner M, Scholmerich J, Straub RH. Serum levels of pregnenolone and 17-hydroxypregnenolone in patients with rheumatoid arthritis and systemic lupus erythematosus: relation to other adrenal hormones. J Rheumatol 2003;30:269-75.
96. Straub RH, Pongratz G, Scholmerich J, Kees F, Schaible TF, Antoni C, et al. Long-term anti-tumor necrosis factor antibody therapy in rheumatoid arthritis patients sensitizes the pituitary gland and favors adrenal androgen secretion. Arthritis Rheum 2003;48:1504-12.
97. Straub RH, Harle P, Atzeni F, Weidler C, Cutolo M, Sarzi-Puttini P. Sex hormone concentrations in patients with rheumatoid arthritis are not normalized during 12 weeks of anti-tumor necrosis factor therapy. J Rheumatol 2005;32: 1253-7.
98. Masi AT, Aldag JC, Chatterton RT, Malamet RL. Basal steroidogenesis was normal before clinical onset of rheumatoid arthritis (pre-RA) in postmenopausal women and men, despite marked differences by gender, and gender dimorphisms of correlations with TNF-alpha. Arthritis Rheum 2003;48 Suppl 344.
99. McEwen BS. Protective and damaging effects of stress mediators. N Engl J Med 1998;338:171-9.
100. StClair EW, Pisetsky DS, Haynes BF editors. Rheumatoid arthritis. Philadelphia: Lippincott Williams & Wilkins, 2004.